nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—MPO—hematologic cancer	0.218	1	CbGaD
L-Carnitine—XDH—Procarbazine—hematologic cancer	0.111	0.251	CbGbCtD
L-Carnitine—SLC22A16—Doxorubicin—hematologic cancer	0.0901	0.204	CbGbCtD
L-Carnitine—XDH—Daunorubicin—hematologic cancer	0.0595	0.135	CbGbCtD
L-Carnitine—XDH—Mercaptopurine—hematologic cancer	0.0461	0.104	CbGbCtD
L-Carnitine—CES1—Irinotecan—hematologic cancer	0.0329	0.0746	CbGbCtD
L-Carnitine—XDH—Cisplatin—hematologic cancer	0.0232	0.0526	CbGbCtD
L-Carnitine—MPO—Cisplatin—hematologic cancer	0.0232	0.0526	CbGbCtD
L-Carnitine—SLC22A8—Mercaptopurine—hematologic cancer	0.0169	0.0383	CbGbCtD
L-Carnitine—XDH—Doxorubicin—hematologic cancer	0.0155	0.0352	CbGbCtD
L-Carnitine—SLCO1B1—Irinotecan—hematologic cancer	0.0113	0.0257	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—hematologic cancer	0.00599	0.0136	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—hematologic cancer	0.00553	0.0125	CbGbCtD
L-Carnitine—SLC22A16—gonad—hematologic cancer	0.00307	0.0442	CbGeAlD
L-Carnitine—SLC22A16—blood—hematologic cancer	0.00268	0.0385	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—hematologic cancer	0.00259	0.0372	CbGeAlD
L-Carnitine—SLC22A16—testis—hematologic cancer	0.00221	0.0318	CbGeAlD
L-Carnitine—CPT1A—hematopoietic system—hematologic cancer	0.002	0.0287	CbGeAlD
L-Carnitine—CROT—blood—hematologic cancer	0.00193	0.0278	CbGeAlD
L-Carnitine—CPT2—hematopoietic system—hematologic cancer	0.0019	0.0273	CbGeAlD
L-Carnitine—CRAT—gonad—hematologic cancer	0.00187	0.0269	CbGeAlD
L-Carnitine—CROT—bone marrow—hematologic cancer	0.00187	0.0269	CbGeAlD
L-Carnitine—SLC25A29—lung—hematologic cancer	0.00185	0.0266	CbGeAlD
L-Carnitine—SLC25A29—testis—hematologic cancer	0.00174	0.0251	CbGeAlD
L-Carnitine—CROT—lung—hematologic cancer	0.0017	0.0244	CbGeAlD
L-Carnitine—SLC25A20—blood—hematologic cancer	0.00168	0.0242	CbGeAlD
L-Carnitine—CRAT—blood—hematologic cancer	0.00163	0.0235	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—hematologic cancer	0.00163	0.0234	CbGeAlD
L-Carnitine—CROT—testis—hematologic cancer	0.0016	0.023	CbGeAlD
L-Carnitine—CRAT—bone marrow—hematologic cancer	0.00158	0.0227	CbGeAlD
L-Carnitine—CPT1A—gonad—hematologic cancer	0.00152	0.0218	CbGeAlD
L-Carnitine—CROT—Vinorelbine—Vinblastine—hematologic cancer	0.00151	0.5	CbGdCrCtD
L-Carnitine—CROT—Vinorelbine—Vincristine—hematologic cancer	0.00151	0.5	CbGdCrCtD
L-Carnitine—SLC25A20—lung—hematologic cancer	0.00148	0.0212	CbGeAlD
L-Carnitine—CPT2—gonad—hematologic cancer	0.00144	0.0207	CbGeAlD
L-Carnitine—CRAT—lung—hematologic cancer	0.00143	0.0206	CbGeAlD
L-Carnitine—SLC25A20—testis—hematologic cancer	0.00139	0.02	CbGeAlD
L-Carnitine—CRAT—testis—hematologic cancer	0.00135	0.0194	CbGeAlD
L-Carnitine—CPT1A—blood—hematologic cancer	0.00132	0.019	CbGeAlD
L-Carnitine—SLC25A29—lymph node—hematologic cancer	0.00126	0.0182	CbGeAlD
L-Carnitine—CPT2—blood—hematologic cancer	0.00126	0.0181	CbGeAlD
L-Carnitine—CPT2—bone marrow—hematologic cancer	0.00122	0.0175	CbGeAlD
L-Carnitine—CPT1A—lung—hematologic cancer	0.00116	0.0167	CbGeAlD
L-Carnitine—CROT—lymph node—hematologic cancer	0.00116	0.0167	CbGeAlD
L-Carnitine—CES1—hematopoietic system—hematologic cancer	0.00113	0.0162	CbGeAlD
L-Carnitine—CPT2—lung—hematologic cancer	0.0011	0.0158	CbGeAlD
L-Carnitine—CPT1A—testis—hematologic cancer	0.00109	0.0157	CbGeAlD
L-Carnitine—CPT2—testis—hematologic cancer	0.00104	0.0149	CbGeAlD
L-Carnitine—SLC25A20—lymph node—hematologic cancer	0.00101	0.0145	CbGeAlD
L-Carnitine—CRAT—lymph node—hematologic cancer	0.000979	0.0141	CbGeAlD
L-Carnitine—SLCO1B1—hematopoietic system—hematologic cancer	0.000967	0.0139	CbGeAlD
L-Carnitine—MPO—hematopoietic system—hematologic cancer	0.00094	0.0135	CbGeAlD
L-Carnitine—CPT1A—lymph node—hematologic cancer	0.000793	0.0114	CbGeAlD
L-Carnitine—CPT2—lymph node—hematologic cancer	0.000753	0.0108	CbGeAlD
L-Carnitine—SLC22A8—hematopoietic system—hematologic cancer	0.000751	0.0108	CbGeAlD
L-Carnitine—Choline—PDE4B—hematologic cancer	0.000748	0.56	CrCbGaD
L-Carnitine—CES1—blood—hematologic cancer	0.000746	0.0107	CbGeAlD
L-Carnitine—CES1—lung—hematologic cancer	0.000654	0.0094	CbGeAlD
L-Carnitine—SLCO1B1—blood—hematologic cancer	0.000641	0.00921	CbGeAlD
L-Carnitine—MPO—blood—hematologic cancer	0.000623	0.00896	CbGeAlD
L-Carnitine—CES1—testis—hematologic cancer	0.000617	0.00887	CbGeAlD
L-Carnitine—MPO—bone marrow—hematologic cancer	0.000603	0.00867	CbGeAlD
L-Carnitine—Choline—SLC22A1—hematologic cancer	0.000588	0.44	CrCbGaD
L-Carnitine—SLC22A4—blood—hematologic cancer	0.000569	0.00818	CbGeAlD
L-Carnitine—SLC22A4—bone marrow—hematologic cancer	0.00055	0.00791	CbGeAlD
L-Carnitine—MPO—lung—hematologic cancer	0.000546	0.00785	CbGeAlD
L-Carnitine—MPO—testis—hematologic cancer	0.000515	0.00741	CbGeAlD
L-Carnitine—SLC22A4—lung—hematologic cancer	0.000499	0.00717	CbGeAlD
L-Carnitine—SLC22A8—blood—hematologic cancer	0.000498	0.00716	CbGeAlD
L-Carnitine—CES1—lymph node—hematologic cancer	0.000447	0.00643	CbGeAlD
L-Carnitine—SLC22A5—blood—hematologic cancer	0.000376	0.00541	CbGeAlD
L-Carnitine—MPO—lymph node—hematologic cancer	0.000373	0.00537	CbGeAlD
L-Carnitine—SLC22A4—lymph node—hematologic cancer	0.000341	0.0049	CbGeAlD
L-Carnitine—SLC22A5—lung—hematologic cancer	0.00033	0.00474	CbGeAlD
L-Carnitine—SLC22A5—testis—hematologic cancer	0.000311	0.00448	CbGeAlD
L-Carnitine—SLC22A5—lymph node—hematologic cancer	0.000226	0.00324	CbGeAlD
L-Carnitine—Vertigo—Prednisone—hematologic cancer	3.86e-05	0.000236	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—hematologic cancer	3.86e-05	0.000236	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—hematologic cancer	3.85e-05	0.000236	CcSEcCtD
L-Carnitine—Vomiting—Vincristine—hematologic cancer	3.84e-05	0.000235	CcSEcCtD
L-Carnitine—Anorexia—Betamethasone—hematologic cancer	3.84e-05	0.000235	CcSEcCtD
L-Carnitine—Anorexia—Dexamethasone—hematologic cancer	3.84e-05	0.000235	CcSEcCtD
L-Carnitine—Asthenia—Cisplatin—hematologic cancer	3.83e-05	0.000234	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—hematologic cancer	3.83e-05	0.000234	CcSEcCtD
L-Carnitine—Rash—Vincristine—hematologic cancer	3.81e-05	0.000233	CcSEcCtD
L-Carnitine—Dermatitis—Vincristine—hematologic cancer	3.8e-05	0.000233	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—hematologic cancer	3.8e-05	0.000233	CcSEcCtD
L-Carnitine—Pain—Triamcinolone—hematologic cancer	3.79e-05	0.000232	CcSEcCtD
L-Carnitine—Headache—Vincristine—hematologic cancer	3.78e-05	0.000231	CcSEcCtD
L-Carnitine—Hypotension—Betamethasone—hematologic cancer	3.76e-05	0.00023	CcSEcCtD
L-Carnitine—Hypotension—Dexamethasone—hematologic cancer	3.76e-05	0.00023	CcSEcCtD
L-Carnitine—Nausea—Carmustine—hematologic cancer	3.76e-05	0.00023	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—hematologic cancer	3.74e-05	0.000229	CcSEcCtD
L-Carnitine—Vomiting—Mitoxantrone—hematologic cancer	3.74e-05	0.000229	CcSEcCtD
L-Carnitine—Vomiting—Irinotecan—hematologic cancer	3.74e-05	0.000229	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—hematologic cancer	3.73e-05	0.000228	CcSEcCtD
L-Carnitine—Nausea—Alitretinoin—hematologic cancer	3.72e-05	0.000228	CcSEcCtD
L-Carnitine—Convulsion—Prednisone—hematologic cancer	3.72e-05	0.000228	CcSEcCtD
L-Carnitine—Hypertension—Prednisone—hematologic cancer	3.71e-05	0.000227	CcSEcCtD
L-Carnitine—Rash—Irinotecan—hematologic cancer	3.71e-05	0.000227	CcSEcCtD
L-Carnitine—Rash—Mitoxantrone—hematologic cancer	3.71e-05	0.000227	CcSEcCtD
L-Carnitine—Dermatitis—Mitoxantrone—hematologic cancer	3.71e-05	0.000227	CcSEcCtD
L-Carnitine—Dermatitis—Irinotecan—hematologic cancer	3.71e-05	0.000227	CcSEcCtD
L-Carnitine—Headache—Irinotecan—hematologic cancer	3.68e-05	0.000225	CcSEcCtD
L-Carnitine—Headache—Mitoxantrone—hematologic cancer	3.68e-05	0.000225	CcSEcCtD
L-Carnitine—Nausea—Ifosfamide—hematologic cancer	3.68e-05	0.000225	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.67e-05	0.000224	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.67e-05	0.000224	CcSEcCtD
L-Carnitine—Myalgia—Prednisone—hematologic cancer	3.66e-05	0.000224	CcSEcCtD
L-Carnitine—Diarrhoea—Cisplatin—hematologic cancer	3.65e-05	0.000224	CcSEcCtD
L-Carnitine—Anxiety—Prednisone—hematologic cancer	3.65e-05	0.000223	CcSEcCtD
L-Carnitine—Vomiting—Gemcitabine—hematologic cancer	3.64e-05	0.000223	CcSEcCtD
L-Carnitine—Insomnia—Dexamethasone—hematologic cancer	3.64e-05	0.000223	CcSEcCtD
L-Carnitine—Insomnia—Betamethasone—hematologic cancer	3.64e-05	0.000223	CcSEcCtD
L-Carnitine—Paraesthesia—Betamethasone—hematologic cancer	3.62e-05	0.000221	CcSEcCtD
L-Carnitine—Paraesthesia—Dexamethasone—hematologic cancer	3.62e-05	0.000221	CcSEcCtD
L-Carnitine—Rash—Gemcitabine—hematologic cancer	3.61e-05	0.000221	CcSEcCtD
L-Carnitine—Dermatitis—Gemcitabine—hematologic cancer	3.61e-05	0.000221	CcSEcCtD
L-Carnitine—Eye disorder—Epirubicin—hematologic cancer	3.61e-05	0.000221	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—hematologic cancer	3.6e-05	0.00022	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—hematologic cancer	3.59e-05	0.00022	CcSEcCtD
L-Carnitine—Headache—Gemcitabine—hematologic cancer	3.59e-05	0.00022	CcSEcCtD
L-Carnitine—Nausea—Vincristine—hematologic cancer	3.59e-05	0.000219	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—hematologic cancer	3.58e-05	0.000219	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—hematologic cancer	3.57e-05	0.000218	CcSEcCtD
L-Carnitine—Hypersensitivity—Prednisolone—hematologic cancer	3.56e-05	0.000217	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—hematologic cancer	3.55e-05	0.000217	CcSEcCtD
L-Carnitine—Dyspepsia—Dexamethasone—hematologic cancer	3.54e-05	0.000217	CcSEcCtD
L-Carnitine—Dyspepsia—Betamethasone—hematologic cancer	3.54e-05	0.000217	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—hematologic cancer	3.52e-05	0.000215	CcSEcCtD
L-Carnitine—Dysgeusia—Methotrexate—hematologic cancer	3.52e-05	0.000215	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—hematologic cancer	3.51e-05	0.000215	CcSEcCtD
L-Carnitine—Body temperature increased—Triamcinolone—hematologic cancer	3.51e-05	0.000215	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—hematologic cancer	3.5e-05	0.000214	CcSEcCtD
L-Carnitine—Decreased appetite—Dexamethasone—hematologic cancer	3.5e-05	0.000214	CcSEcCtD
L-Carnitine—Decreased appetite—Betamethasone—hematologic cancer	3.5e-05	0.000214	CcSEcCtD
L-Carnitine—Nausea—Irinotecan—hematologic cancer	3.49e-05	0.000214	CcSEcCtD
L-Carnitine—Nausea—Mitoxantrone—hematologic cancer	3.49e-05	0.000214	CcSEcCtD
L-Carnitine—Infection—Prednisone—hematologic cancer	3.48e-05	0.000213	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.48e-05	0.000213	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.48e-05	0.000213	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—hematologic cancer	3.47e-05	0.000212	CcSEcCtD
L-Carnitine—Pruritus—Etoposide—hematologic cancer	3.46e-05	0.000212	CcSEcCtD
L-Carnitine—Arrhythmia—Epirubicin—hematologic cancer	3.45e-05	0.000211	CcSEcCtD
L-Carnitine—Pain—Betamethasone—hematologic cancer	3.44e-05	0.000211	CcSEcCtD
L-Carnitine—Pain—Dexamethasone—hematologic cancer	3.44e-05	0.000211	CcSEcCtD
L-Carnitine—Tachycardia—Prednisone—hematologic cancer	3.42e-05	0.000209	CcSEcCtD
L-Carnitine—Nausea—Gemcitabine—hematologic cancer	3.4e-05	0.000208	CcSEcCtD
L-Carnitine—Vomiting—Cisplatin—hematologic cancer	3.4e-05	0.000208	CcSEcCtD
L-Carnitine—Rash—Cisplatin—hematologic cancer	3.37e-05	0.000206	CcSEcCtD
L-Carnitine—Dermatitis—Cisplatin—hematologic cancer	3.36e-05	0.000206	CcSEcCtD
L-Carnitine—Diarrhoea—Etoposide—hematologic cancer	3.35e-05	0.000205	CcSEcCtD
L-Carnitine—Anorexia—Prednisone—hematologic cancer	3.34e-05	0.000204	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—hematologic cancer	3.34e-05	0.000204	CcSEcCtD
L-Carnitine—Anaemia—Methotrexate—hematologic cancer	3.32e-05	0.000203	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.29e-05	0.000201	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.29e-05	0.000201	CcSEcCtD
L-Carnitine—Dysgeusia—Epirubicin—hematologic cancer	3.29e-05	0.000201	CcSEcCtD
L-Carnitine—Hypersensitivity—Triamcinolone—hematologic cancer	3.27e-05	0.0002	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—hematologic cancer	3.25e-05	0.000199	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—hematologic cancer	3.24e-05	0.000198	CcSEcCtD
L-Carnitine—Dizziness—Etoposide—hematologic cancer	3.24e-05	0.000198	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—hematologic cancer	3.23e-05	0.000198	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—hematologic cancer	3.23e-05	0.000197	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.19e-05	0.000195	CcSEcCtD
L-Carnitine—Dizziness—Prednisolone—hematologic cancer	3.19e-05	0.000195	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—hematologic cancer	3.19e-05	0.000195	CcSEcCtD
L-Carnitine—Asthenia—Triamcinolone—hematologic cancer	3.18e-05	0.000195	CcSEcCtD
L-Carnitine—Abdominal pain—Dexamethasone—hematologic cancer	3.18e-05	0.000195	CcSEcCtD
L-Carnitine—Abdominal pain—Betamethasone—hematologic cancer	3.18e-05	0.000195	CcSEcCtD
L-Carnitine—Body temperature increased—Betamethasone—hematologic cancer	3.18e-05	0.000195	CcSEcCtD
L-Carnitine—Body temperature increased—Dexamethasone—hematologic cancer	3.18e-05	0.000195	CcSEcCtD
L-Carnitine—Nausea—Cisplatin—hematologic cancer	3.17e-05	0.000194	CcSEcCtD
L-Carnitine—Insomnia—Prednisone—hematologic cancer	3.17e-05	0.000194	CcSEcCtD
L-Carnitine—Paraesthesia—Prednisone—hematologic cancer	3.15e-05	0.000193	CcSEcCtD
L-Carnitine—Pruritus—Triamcinolone—hematologic cancer	3.14e-05	0.000192	CcSEcCtD
L-Carnitine—Cough—Methotrexate—hematologic cancer	3.13e-05	0.000192	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—hematologic cancer	3.11e-05	0.00019	CcSEcCtD
L-Carnitine—Vomiting—Etoposide—hematologic cancer	3.11e-05	0.00019	CcSEcCtD
L-Carnitine—Anaemia—Epirubicin—hematologic cancer	3.11e-05	0.00019	CcSEcCtD
L-Carnitine—Dyspepsia—Prednisone—hematologic cancer	3.09e-05	0.000189	CcSEcCtD
L-Carnitine—Rash—Etoposide—hematologic cancer	3.08e-05	0.000189	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—hematologic cancer	3.08e-05	0.000189	CcSEcCtD
L-Carnitine—Headache—Etoposide—hematologic cancer	3.07e-05	0.000187	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—hematologic cancer	3.06e-05	0.000187	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—hematologic cancer	3.06e-05	0.000187	CcSEcCtD
L-Carnitine—Decreased appetite—Prednisone—hematologic cancer	3.05e-05	0.000186	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—hematologic cancer	3.04e-05	0.000186	CcSEcCtD
L-Carnitine—Rash—Prednisolone—hematologic cancer	3.04e-05	0.000186	CcSEcCtD
L-Carnitine—Dermatitis—Prednisolone—hematologic cancer	3.04e-05	0.000186	CcSEcCtD
L-Carnitine—Headache—Prednisolone—hematologic cancer	3.02e-05	0.000185	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—hematologic cancer	3.02e-05	0.000185	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—hematologic cancer	3.01e-05	0.000184	CcSEcCtD
L-Carnitine—Constipation—Prednisone—hematologic cancer	3e-05	0.000183	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—hematologic cancer	2.99e-05	0.000183	CcSEcCtD
L-Carnitine—Palpitations—Epirubicin—hematologic cancer	2.97e-05	0.000182	CcSEcCtD
L-Carnitine—Dizziness—Triamcinolone—hematologic cancer	2.93e-05	0.000179	CcSEcCtD
L-Carnitine—Cough—Epirubicin—hematologic cancer	2.93e-05	0.000179	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—hematologic cancer	2.91e-05	0.000178	CcSEcCtD
L-Carnitine—Infection—Methotrexate—hematologic cancer	2.91e-05	0.000178	CcSEcCtD
L-Carnitine—Nausea—Etoposide—hematologic cancer	2.91e-05	0.000178	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—hematologic cancer	2.9e-05	0.000177	CcSEcCtD
L-Carnitine—Asthenia—Dexamethasone—hematologic cancer	2.89e-05	0.000177	CcSEcCtD
L-Carnitine—Asthenia—Betamethasone—hematologic cancer	2.89e-05	0.000177	CcSEcCtD
L-Carnitine—Anaemia—Doxorubicin—hematologic cancer	2.87e-05	0.000176	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Prednisone—hematologic cancer	2.87e-05	0.000175	CcSEcCtD
L-Carnitine—Nausea—Prednisolone—hematologic cancer	2.87e-05	0.000175	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—hematologic cancer	2.86e-05	0.000175	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—hematologic cancer	2.86e-05	0.000175	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—hematologic cancer	2.85e-05	0.000174	CcSEcCtD
L-Carnitine—Pruritus—Dexamethasone—hematologic cancer	2.85e-05	0.000174	CcSEcCtD
L-Carnitine—Pruritus—Betamethasone—hematologic cancer	2.85e-05	0.000174	CcSEcCtD
L-Carnitine—Vomiting—Triamcinolone—hematologic cancer	2.82e-05	0.000173	CcSEcCtD
L-Carnitine—Rash—Triamcinolone—hematologic cancer	2.8e-05	0.000171	CcSEcCtD
L-Carnitine—Dermatitis—Triamcinolone—hematologic cancer	2.8e-05	0.000171	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—hematologic cancer	2.79e-05	0.000171	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—hematologic cancer	2.79e-05	0.000171	CcSEcCtD
L-Carnitine—Headache—Triamcinolone—hematologic cancer	2.78e-05	0.00017	CcSEcCtD
L-Carnitine—Abdominal pain—Prednisone—hematologic cancer	2.77e-05	0.00017	CcSEcCtD
L-Carnitine—Body temperature increased—Prednisone—hematologic cancer	2.77e-05	0.00017	CcSEcCtD
L-Carnitine—Diarrhoea—Dexamethasone—hematologic cancer	2.76e-05	0.000169	CcSEcCtD
L-Carnitine—Diarrhoea—Betamethasone—hematologic cancer	2.76e-05	0.000169	CcSEcCtD
L-Carnitine—Palpitations—Doxorubicin—hematologic cancer	2.75e-05	0.000168	CcSEcCtD
L-Carnitine—Hypotension—Methotrexate—hematologic cancer	2.74e-05	0.000167	CcSEcCtD
L-Carnitine—Infection—Epirubicin—hematologic cancer	2.72e-05	0.000167	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—hematologic cancer	2.71e-05	0.000166	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—hematologic cancer	2.69e-05	0.000165	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—hematologic cancer	2.68e-05	0.000164	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—hematologic cancer	2.68e-05	0.000164	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.67e-05	0.000163	CcSEcCtD
L-Carnitine—Dizziness—Dexamethasone—hematologic cancer	2.66e-05	0.000163	CcSEcCtD
L-Carnitine—Dizziness—Betamethasone—hematologic cancer	2.66e-05	0.000163	CcSEcCtD
L-Carnitine—Insomnia—Methotrexate—hematologic cancer	2.65e-05	0.000162	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—hematologic cancer	2.65e-05	0.000162	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—hematologic cancer	2.65e-05	0.000162	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—hematologic cancer	2.64e-05	0.000161	CcSEcCtD
L-Carnitine—Nausea—Triamcinolone—hematologic cancer	2.64e-05	0.000161	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—hematologic cancer	2.63e-05	0.000161	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—hematologic cancer	2.61e-05	0.00016	CcSEcCtD
L-Carnitine—Dyspnoea—Methotrexate—hematologic cancer	2.61e-05	0.00016	CcSEcCtD
L-Carnitine—Hypersensitivity—Prednisone—hematologic cancer	2.58e-05	0.000158	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—hematologic cancer	2.58e-05	0.000158	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—hematologic cancer	2.56e-05	0.000157	CcSEcCtD
L-Carnitine—Vomiting—Betamethasone—hematologic cancer	2.56e-05	0.000157	CcSEcCtD
L-Carnitine—Vomiting—Dexamethasone—hematologic cancer	2.56e-05	0.000157	CcSEcCtD
L-Carnitine—Decreased appetite—Methotrexate—hematologic cancer	2.55e-05	0.000156	CcSEcCtD
L-Carnitine—Rash—Dexamethasone—hematologic cancer	2.54e-05	0.000155	CcSEcCtD
L-Carnitine—Rash—Betamethasone—hematologic cancer	2.54e-05	0.000155	CcSEcCtD
L-Carnitine—Dermatitis—Betamethasone—hematologic cancer	2.54e-05	0.000155	CcSEcCtD
L-Carnitine—Dermatitis—Dexamethasone—hematologic cancer	2.54e-05	0.000155	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.53e-05	0.000155	CcSEcCtD
L-Carnitine—Headache—Dexamethasone—hematologic cancer	2.52e-05	0.000154	CcSEcCtD
L-Carnitine—Headache—Betamethasone—hematologic cancer	2.52e-05	0.000154	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—hematologic cancer	2.52e-05	0.000154	CcSEcCtD
L-Carnitine—Asthenia—Prednisone—hematologic cancer	2.52e-05	0.000154	CcSEcCtD
L-Carnitine—Pain—Methotrexate—hematologic cancer	2.51e-05	0.000153	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.5e-05	0.000153	CcSEcCtD
L-Carnitine—Pruritus—Prednisone—hematologic cancer	2.48e-05	0.000152	CcSEcCtD
L-Carnitine—Insomnia—Epirubicin—hematologic cancer	2.48e-05	0.000152	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—hematologic cancer	2.48e-05	0.000151	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—hematologic cancer	2.46e-05	0.000151	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—hematologic cancer	2.45e-05	0.00015	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—hematologic cancer	2.42e-05	0.000148	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—hematologic cancer	2.41e-05	0.000148	CcSEcCtD
L-Carnitine—Diarrhoea—Prednisone—hematologic cancer	2.4e-05	0.000147	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.4e-05	0.000147	CcSEcCtD
L-Carnitine—Nausea—Betamethasone—hematologic cancer	2.39e-05	0.000146	CcSEcCtD
L-Carnitine—Nausea—Dexamethasone—hematologic cancer	2.39e-05	0.000146	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—hematologic cancer	2.38e-05	0.000146	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—hematologic cancer	2.37e-05	0.000145	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.37e-05	0.000145	CcSEcCtD
L-Carnitine—Pain—Epirubicin—hematologic cancer	2.35e-05	0.000143	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—hematologic cancer	2.35e-05	0.000143	CcSEcCtD
L-Carnitine—Dizziness—Prednisone—hematologic cancer	2.32e-05	0.000142	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—hematologic cancer	2.32e-05	0.000142	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—hematologic cancer	2.32e-05	0.000142	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.31e-05	0.000141	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—hematologic cancer	2.3e-05	0.00014	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—hematologic cancer	2.28e-05	0.000139	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—hematologic cancer	2.26e-05	0.000138	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.24e-05	0.000137	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—hematologic cancer	2.23e-05	0.000137	CcSEcCtD
L-Carnitine—Vomiting—Prednisone—hematologic cancer	2.23e-05	0.000136	CcSEcCtD
L-Carnitine—Rash—Prednisone—hematologic cancer	2.21e-05	0.000135	CcSEcCtD
L-Carnitine—Dermatitis—Prednisone—hematologic cancer	2.21e-05	0.000135	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—hematologic cancer	2.21e-05	0.000135	CcSEcCtD
L-Carnitine—Headache—Prednisone—hematologic cancer	2.2e-05	0.000134	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.19e-05	0.000134	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—hematologic cancer	2.17e-05	0.000133	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—hematologic cancer	2.17e-05	0.000133	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—hematologic cancer	2.17e-05	0.000133	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—hematologic cancer	2.17e-05	0.000133	CcSEcCtD
L-Carnitine—Hypersensitivity—Methotrexate—hematologic cancer	2.16e-05	0.000132	CcSEcCtD
L-Carnitine—Asthenia—Methotrexate—hematologic cancer	2.1e-05	0.000129	CcSEcCtD
L-Carnitine—Nausea—Prednisone—hematologic cancer	2.08e-05	0.000127	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.08e-05	0.000127	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—hematologic cancer	2.07e-05	0.000127	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.04e-05	0.000197	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.04e-05	0.000196	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.02e-05	0.000195	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Epirubicin—hematologic cancer	2.02e-05	0.000124	CcSEcCtD
L-Carnitine—CROT—Metabolism—CREBBP—hematologic cancer	2.02e-05	0.000195	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALOX5—hematologic cancer	2.01e-05	0.000194	CbGpPWpGaD
L-Carnitine—Abdominal pain—Doxorubicin—hematologic cancer	2.01e-05	0.000123	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—hematologic cancer	2.01e-05	0.000123	CcSEcCtD
L-Carnitine—Diarrhoea—Methotrexate—hematologic cancer	2.01e-05	0.000123	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.99e-05	0.000192	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYCS—hematologic cancer	1.98e-05	0.000191	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.98e-05	0.000191	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—HSP90AA1—hematologic cancer	1.97e-05	0.00019	CbGpPWpGaD
L-Carnitine—Asthenia—Epirubicin—hematologic cancer	1.97e-05	0.00012	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.95e-05	0.000188	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NUP98—hematologic cancer	1.95e-05	0.000188	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.94e-05	0.000187	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.94e-05	0.000187	CbGpPWpGaD
L-Carnitine—Pruritus—Epirubicin—hematologic cancer	1.94e-05	0.000119	CcSEcCtD
L-Carnitine—Dizziness—Methotrexate—hematologic cancer	1.94e-05	0.000119	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—hematologic cancer	1.93e-05	0.000186	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CD—hematologic cancer	1.92e-05	0.000185	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.91e-05	0.000184	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.91e-05	0.000184	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FTCD—hematologic cancer	1.89e-05	0.000183	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PHYH—hematologic cancer	1.89e-05	0.000183	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GMPS—hematologic cancer	1.89e-05	0.000183	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ADCY7—hematologic cancer	1.89e-05	0.000182	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NCOA3—hematologic cancer	1.89e-05	0.000182	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ALB—hematologic cancer	1.89e-05	0.000182	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—FHL2—hematologic cancer	1.89e-05	0.000182	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NUP214—hematologic cancer	1.88e-05	0.000181	CbGpPWpGaD
L-Carnitine—Diarrhoea—Epirubicin—hematologic cancer	1.88e-05	0.000115	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.88e-05	0.000181	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Doxorubicin—hematologic cancer	1.87e-05	0.000114	CcSEcCtD
L-Carnitine—Vomiting—Methotrexate—hematologic cancer	1.86e-05	0.000114	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.86e-05	0.000179	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AGRN—hematologic cancer	1.85e-05	0.000179	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.85e-05	0.000179	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CG—hematologic cancer	1.85e-05	0.000179	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CG—hematologic cancer	1.85e-05	0.000179	CbGpPWpGaD
L-Carnitine—Rash—Methotrexate—hematologic cancer	1.85e-05	0.000113	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—hematologic cancer	1.85e-05	0.000113	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.84e-05	0.000177	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTR—hematologic cancer	1.84e-05	0.000177	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCG2—hematologic cancer	1.84e-05	0.000177	CbGpPWpGaD
L-Carnitine—Headache—Methotrexate—hematologic cancer	1.84e-05	0.000112	CcSEcCtD
L-Carnitine—Asthenia—Doxorubicin—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—hematologic cancer	1.81e-05	0.000111	CcSEcCtD
L-Carnitine—CROT—Metabolism—PIK3R1—hematologic cancer	1.81e-05	0.000174	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ENO2—hematologic cancer	1.8e-05	0.000174	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.8e-05	0.000174	CbGpPWpGaD
L-Carnitine—Pruritus—Doxorubicin—hematologic cancer	1.8e-05	0.00011	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.79e-05	0.000172	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.78e-05	0.000171	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.78e-05	0.000171	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—hematologic cancer	1.77e-05	0.00017	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.77e-05	0.00017	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HMMR—hematologic cancer	1.76e-05	0.00017	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—IDH2—hematologic cancer	1.76e-05	0.00017	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTT1—hematologic cancer	1.75e-05	0.000169	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTP1—hematologic cancer	1.75e-05	0.000169	CbGpPWpGaD
L-Carnitine—Vomiting—Epirubicin—hematologic cancer	1.74e-05	0.000107	CcSEcCtD
L-Carnitine—Nausea—Methotrexate—hematologic cancer	1.74e-05	0.000106	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—hematologic cancer	1.74e-05	0.000106	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism—SMPD3—hematologic cancer	1.73e-05	0.000167	CbGpPWpGaD
L-Carnitine—Rash—Epirubicin—hematologic cancer	1.73e-05	0.000106	CcSEcCtD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.73e-05	0.000167	CbGpPWpGaD
L-Carnitine—Dermatitis—Epirubicin—hematologic cancer	1.73e-05	0.000106	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.72e-05	0.000166	CbGpPWpGaD
L-Carnitine—Headache—Epirubicin—hematologic cancer	1.72e-05	0.000105	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CREBBP—hematologic cancer	1.72e-05	0.000166	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CREBBP—hematologic cancer	1.72e-05	0.000166	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SDC1—hematologic cancer	1.71e-05	0.000165	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.69e-05	0.000163	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.68e-05	0.000162	CbGpPWpGaD
L-Carnitine—Dizziness—Doxorubicin—hematologic cancer	1.68e-05	0.000103	CcSEcCtD
L-Carnitine—CROT—Metabolism—PIK3CB—hematologic cancer	1.67e-05	0.000161	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ABCB1—hematologic cancer	1.66e-05	0.00016	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.66e-05	0.00016	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ARNTL—hematologic cancer	1.65e-05	0.000159	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.63e-05	0.000158	CbGpPWpGaD
L-Carnitine—Nausea—Epirubicin—hematologic cancer	1.63e-05	9.96e-05	CcSEcCtD
L-Carnitine—CRAT—Metabolism—PIK3CD—hematologic cancer	1.63e-05	0.000157	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CD—hematologic cancer	1.63e-05	0.000157	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.62e-05	0.000156	CbGpPWpGaD
L-Carnitine—Vomiting—Doxorubicin—hematologic cancer	1.61e-05	9.87e-05	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALB—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALB—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NCOR1—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA9—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ACP5—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTM1—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.61e-05	0.000155	CbGpPWpGaD
L-Carnitine—Rash—Doxorubicin—hematologic cancer	1.6e-05	9.79e-05	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—hematologic cancer	1.6e-05	9.78e-05	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—hematologic cancer	1.59e-05	9.72e-05	CcSEcCtD
L-Carnitine—XDH—Metabolism—NCOR2—hematologic cancer	1.59e-05	0.000153	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.57e-05	0.000152	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.54e-05	0.000149	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3R1—hematologic cancer	1.54e-05	0.000148	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3R1—hematologic cancer	1.54e-05	0.000148	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.54e-05	0.000148	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.53e-05	0.000148	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—B3GAT1—hematologic cancer	1.51e-05	0.000146	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—DCK—hematologic cancer	1.51e-05	0.000146	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ASNS—hematologic cancer	1.51e-05	0.000146	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—IDH1—hematologic cancer	1.51e-05	0.000146	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—hematologic cancer	1.51e-05	9.22e-05	CcSEcCtD
L-Carnitine—XDH—Metabolism—TXN—hematologic cancer	1.49e-05	0.000144	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCC3—hematologic cancer	1.49e-05	0.000144	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTO1—hematologic cancer	1.49e-05	0.000144	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.49e-05	0.000144	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.48e-05	0.000143	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SPHK1—hematologic cancer	1.46e-05	0.000141	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CD44—hematologic cancer	1.45e-05	0.00014	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NQO1—hematologic cancer	1.45e-05	0.00014	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.45e-05	0.00014	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—hematologic cancer	1.44e-05	0.000139	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HDC—hematologic cancer	1.44e-05	0.000138	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.42e-05	0.000137	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—MTHFR—hematologic cancer	1.42e-05	0.000137	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CB—hematologic cancer	1.42e-05	0.000137	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CB—hematologic cancer	1.42e-05	0.000137	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.41e-05	0.000136	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—UGT1A1—hematologic cancer	1.41e-05	0.000136	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.4e-05	0.000135	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.39e-05	0.000134	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYCS—hematologic cancer	1.38e-05	0.000133	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—EP300—hematologic cancer	1.38e-05	0.000133	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.37e-05	0.000132	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HSP90AA1—hematologic cancer	1.37e-05	0.000132	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC22A1—hematologic cancer	1.37e-05	0.000132	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CRABP1—hematologic cancer	1.37e-05	0.000132	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.35e-05	0.00013	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.34e-05	0.000129	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALOX5—hematologic cancer	1.33e-05	0.000128	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CDA—hematologic cancer	1.31e-05	0.000127	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NUP98—hematologic cancer	1.29e-05	0.000124	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PC—hematologic cancer	1.26e-05	0.000122	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOA3—hematologic cancer	1.25e-05	0.000121	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ADCY7—hematologic cancer	1.25e-05	0.000121	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.25e-05	0.000121	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.24e-05	0.00012	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NUP214—hematologic cancer	1.24e-05	0.00012	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.23e-05	0.000119	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—hematologic cancer	1.23e-05	0.000118	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—hematologic cancer	1.23e-05	0.000118	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GBA—hematologic cancer	1.22e-05	0.000118	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC35B2—hematologic cancer	1.22e-05	0.000118	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.22e-05	0.000118	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTR—hematologic cancer	1.22e-05	0.000117	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCG2—hematologic cancer	1.22e-05	0.000117	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—hematologic cancer	1.21e-05	0.000117	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ENO2—hematologic cancer	1.19e-05	0.000115	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—hematologic cancer	1.19e-05	0.000115	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.17e-05	0.000113	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—EP300—hematologic cancer	1.17e-05	0.000113	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—EP300—hematologic cancer	1.17e-05	0.000113	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—hematologic cancer	1.16e-05	0.000112	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCB1—hematologic cancer	1.15e-05	0.000111	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SDC1—hematologic cancer	1.13e-05	0.000109	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.13e-05	0.000109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTAP—hematologic cancer	1.12e-05	0.000108	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—hematologic cancer	1.11e-05	0.000107	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NCOR1—hematologic cancer	1.11e-05	0.000107	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CREBBP—hematologic cancer	1.11e-05	0.000107	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.11e-05	0.000107	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.05e-05	0.000101	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CD—hematologic cancer	1.05e-05	0.000101	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—hematologic cancer	1.04e-05	9.99e-05	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—hematologic cancer	1.04e-05	9.99e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.02e-05	9.88e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—hematologic cancer	1.02e-05	9.81e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FHL2—hematologic cancer	9.95e-06	9.6e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3R1—hematologic cancer	9.91e-06	9.56e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTHFR—hematologic cancer	9.85e-06	9.5e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AGRN—hematologic cancer	9.76e-06	9.41e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CD44—hematologic cancer	9.63e-06	9.29e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NQO1—hematologic cancer	9.63e-06	9.29e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—IDH2—hematologic cancer	9.25e-06	8.92e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMMR—hematologic cancer	9.25e-06	8.92e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CB—hematologic cancer	9.15e-06	8.82e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYCS—hematologic cancer	9.11e-06	8.79e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HSP90AA1—hematologic cancer	9.06e-06	8.73e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.72e-06	8.41e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ARNTL—hematologic cancer	8.7e-06	8.39e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.68e-06	8.37e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—hematologic cancer	8.65e-06	8.34e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—hematologic cancer	8.65e-06	8.34e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.55e-06	8.24e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA9—hematologic cancer	8.46e-06	8.16e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ACP5—hematologic cancer	8.46e-06	8.16e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOR2—hematologic cancer	8.35e-06	8.05e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.32e-06	8.02e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—hematologic cancer	8.31e-06	8.02e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—hematologic cancer	8.28e-06	7.98e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—hematologic cancer	8.03e-06	7.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—IDH1—hematologic cancer	7.96e-06	7.67e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—hematologic cancer	7.9e-06	7.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTO1—hematologic cancer	7.87e-06	7.59e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TXN—hematologic cancer	7.87e-06	7.59e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCC3—hematologic cancer	7.87e-06	7.59e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	7.78e-06	7.51e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SPHK1—hematologic cancer	7.7e-06	7.42e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CREBBP—hematologic cancer	7.67e-06	7.4e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCB1—hematologic cancer	7.6e-06	7.33e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—EP300—hematologic cancer	7.54e-06	7.27e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.52e-06	7.25e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UGT1A1—hematologic cancer	7.4e-06	7.13e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOR1—hematologic cancer	7.38e-06	7.12e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—hematologic cancer	7.38e-06	7.12e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CD—hematologic cancer	7.27e-06	7.01e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CRABP1—hematologic cancer	7.2e-06	6.94e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC22A1—hematologic cancer	7.2e-06	6.94e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—hematologic cancer	7.18e-06	6.92e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—hematologic cancer	7.07e-06	6.82e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—hematologic cancer	7.07e-06	6.82e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	7.04e-06	6.79e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALOX5—hematologic cancer	7.01e-06	6.76e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3R1—hematologic cancer	6.87e-06	6.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NUP98—hematologic cancer	6.79e-06	6.55e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ADCY7—hematologic cancer	6.59e-06	6.36e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA3—hematologic cancer	6.59e-06	6.36e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NUP214—hematologic cancer	6.55e-06	6.31e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTHFR—hematologic cancer	6.52e-06	6.29e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.48e-06	6.25e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCG2—hematologic cancer	6.41e-06	6.18e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTR—hematologic cancer	6.41e-06	6.18e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CB—hematologic cancer	6.34e-06	6.11e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENO2—hematologic cancer	6.29e-06	6.06e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—hematologic cancer	6.1e-06	5.88e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.01e-06	5.79e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SDC1—hematologic cancer	5.96e-06	5.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.71e-06	5.51e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.7e-06	5.49e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.62e-06	5.42e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—hematologic cancer	5.58e-06	5.38e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—hematologic cancer	5.48e-06	5.29e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—hematologic cancer	5.48e-06	5.28e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.38e-06	5.19e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.35e-06	5.15e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—EP300—hematologic cancer	5.23e-06	5.04e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CREBBP—hematologic cancer	5.08e-06	4.9e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CD44—hematologic cancer	5.07e-06	4.89e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NQO1—hematologic cancer	5.07e-06	4.89e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.96e-06	4.79e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CD—hematologic cancer	4.82e-06	4.65e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYCS—hematologic cancer	4.8e-06	4.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSP90AA1—hematologic cancer	4.77e-06	4.6e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—hematologic cancer	4.76e-06	4.59e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—hematologic cancer	4.56e-06	4.39e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3R1—hematologic cancer	4.55e-06	4.39e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.29e-06	4.14e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—hematologic cancer	4.23e-06	4.08e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CB—hematologic cancer	4.2e-06	4.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.09e-06	3.94e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCB1—hematologic cancer	4e-06	3.86e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—hematologic cancer	3.89e-06	3.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOR1—hematologic cancer	3.89e-06	3.75e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—hematologic cancer	3.87e-06	3.73e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—hematologic cancer	3.63e-06	3.5e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—EP300—hematologic cancer	3.46e-06	3.34e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTHFR—hematologic cancer	3.43e-06	3.31e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—hematologic cancer	3.16e-06	3.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.03e-06	2.92e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	2.89e-06	2.78e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	2.67e-06	2.58e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—hematologic cancer	2.56e-06	2.47e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.54e-06	2.45e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—hematologic cancer	2.5e-06	2.41e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.39e-06	2.31e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.21e-06	2.13e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—hematologic cancer	2.09e-06	2.02e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.91e-06	1.84e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—EP300—hematologic cancer	1.82e-06	1.76e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.35e-06	1.3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.1e-06	1.06e-05	CbGpPWpGaD
